You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 2, February 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cerebrospinal Fluid MHPG

An Assessment of Norepinephrine Metabolism in Affective Disorders

Baron Shopsin, MD; Sherwin Wilk, PhD; Samuel Gershon, MD; Kenneth Davis, PhD; Michael Suhl, MD

Arch Gen Psychiatry. 1973;28(2):230-233.


Abstract

The level of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) was measured in the cerebrospinal fluid (CSF) of 27 hospitalized psychiatric patients, the great majority of whom show CSF MHPG levels within the range found in 24 normal control subjects. All depressed patients showed normal CSF MHPG levels. Some manic and schizophrenic patients showed levels elevated beyond the range of controls, with greatest significance attained in the manics. Those patients showing abnormal values did not show clinical-chemicaldemographic characteristics distinguishing them from other patients with the same diagnosis.

Using each patient as his own control and relating the time of spinal tap to symptom onset or change may be a sensitive and relevant index of exploring alterations in CSF MHPG.



Author Affiliations

New York

From the Department of Psychiatry, Neuropsychopharmacology Research Unit (Drs. Shopsin and Gershon) and the Department of Neurology (Dr. Suhl), New York University Medical Center, and the Department of Pharmacology, Mount Sinai School of Medicine of the City University of New York (Drs. Wilk and Davis), New York.


Footnotes

Accepted for publication Aug 14, 1972.

Reprint requests to 550 First Ave, New York 10016 (Dr. Shopsin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT  

Lithium Carbonate Treatment of Mania: Cerebrospinal Fluid and Urinary Monoamine Metabolites and Treatment Outcome
Swann et al.
Arch Gen Psychiatry 1987;44:345-354.
ABSTRACT  

Clinical and Biochemical Heterogeneity of Depressive Disorders
MAAS
ANN INTERN MED 1978;88:556-563.
ABSTRACT  

The Switch Process in Manic-Depressive Psychosis
BUNNEY et al.
ANN INTERN MED 1977;87:319-335.
ABSTRACT  

Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients
Shopsin et al.
Arch Gen Psychiatry 1976;33:811-819.
ABSTRACT  

Biogenic Amines and Depression: Biochemical and Pharmacological Separation of Two Types of Depression
Maas and Maas
Arch Gen Psychiatry 1975;32:1357-1361.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.